Breaking News Instant updates and real-time market news.

RAD

Rite Aid

$4.71

-0.14 (-2.89%)

, WBA

Walgreens Boots Alliance

$84.63

-1.28 (-1.49%)

06:19
03/21/17
03/21
06:19
03/21/17
06:19

Deutsche says Rite Aid could fall 53% if Walgreens deal fails

Deutsche Bank analyst George Hill points out that according to recent media reports, the Federal Trade Commission still has issues with Walgreens Boots Alliance's (WBA) proposed acquisition of Rite Aid (RAD) as well as Fred's (FRED) as a buyer of divested stores. Should the deal fail to close, Walgreens shares have downside to the $73-$79 range, or up to 14%, Hill tells investors in a research note, citing his analysis. Rite Aid shares, the analyst suspects, could fall to $2.25 per share, or 53% from current levels, the analyst contends. He believes a key to Walgreens' decision to certify compliance with the second request could be the current makeup of the FTC, which has three vacant seats along with a Democratic Commissioner and Republican Chairperson. Hill has a Buy rating on Walgreens with a $92 price target, which he notes excludes Rite Aid.

RAD

Rite Aid

$4.71

-0.14 (-2.89%)

WBA

Walgreens Boots Alliance

$84.63

-1.28 (-1.49%)

FRED

Fred's

$14.66

-0.54 (-3.55%)

  • 05

    Apr

  • 06

    Apr

RAD Rite Aid
$4.71

-0.14 (-2.89%)

01/17/17
01/17/17
UPGRADE
Target $95

Outperform
AmerisourceBergen upgraded to Outperform at Leerink
As previously reported, Leerink analyst David Larsen upgraded AmerisourceBergen (ABC) to Outperform from Market Perform and raised his price target on the shares to $95 from $75. The analyst believes the odds of the Walgreens Boots Alliance (WBA)/Rite Aid (RAD) transaction going through have "increased substantially," and believes that the long-term partnership with Walgreens Boots Alliance will act as a positive driver for volumes. Long-term, Larsen believes that AmerisourceBergen will continue to benefit from growth in specialty, biosimilars, and generic launches, while recent commentary seems to indicate that generic deflation trends are moderating.
01/20/17
EVER
01/20/17
NO CHANGE
EVER
Rite Aid could trade to $3.50 or below if deal is not completed, says Evercore ISI
Evercore ISI analyst Ross Muken believes Rite Aid (RAD) could have "massive" downside and would likely trade to $3.50 or below if the acquisition by Walgreens Boots Alliance (WBA) were not completed. For Walgreens, Muken said, if the deal is not completed, it would be a modest negative given the synergy potential and time committed to deal closure, but he expects Walgreen not to sit on the capital for very long and would look for a combination of share repurchases and additional M&A in the not-too-distant future.
01/20/17
01/20/17
NO CHANGE

Rite Aid-Walgreens deal closing 'way more likely than not,' says Cowen
After a Bloomberg article said that the FTC is concerned about the sale of Rite Aid (RAD) stores to Fred's (FRED) as a remedy to concerns about Walgreens' (WBA) takeover deal, Cowen analyst Charles Rhyee said that the report could reflect a split staff at FTC and the losing side making some noise or it could be a public negotiating tactic. Given the various paths forward, including litigation, Rhyee still thinks it is "way more likely than not" that this deal will ultimately close and views the weakness in Walgreens shares as a buying opportunity.
01/30/17
LEER
01/30/17
NO CHANGE
LEER
Outperform
Walgreens Boots Alliance, Rite Aid transaction still in-process, says Leerink
Leerink analyst David Larsen notes that he has confirmed with Walgreens Boots Alliance (WBA) that the deal with Rite Aid (RAD) would only terminate if either party were to walk away, which would require a formal announcement. Therefore, the analyst believes "no news is good news," and that the transaction is still in-process and on track. He reiterates an Outperform rating on Walgreens Boots Alliance's shares.
WBA Walgreens Boots Alliance
$84.63

-1.28 (-1.49%)

02/06/17
ATLE
02/06/17
UPGRADE
ATLE
Overweight
Walgreens Boots upgraded to Overweight from Neutral at Atlantic Equities
FRED Fred's
$14.66

-0.54 (-3.55%)

01/06/17
01/06/17
UPGRADE
Target $17.5

Equal Weight
Fred's upgraded to Equal Weight after Rite Aid pact at Stephens
As previously reported, Stephens analyst Ben Bienvenu upgraded Fred's (FRED) to Equal Weight from Underweight citing the company's agreement to purchase 865 Rite Aid (RAD) stores from Walgreens (WBA), which he acknowledged "could be transformational longer term" if approved by the FTC. However, he also thinks the execution risk is very high in the near-term and notes that the retail pharmacy and discount retail industries are currently very competitive. Bienvenu raised his price target on Fred's shares to $17.50 from $7.
02/07/17
SIDC
02/07/17
UPGRADE
SIDC
Buy
Fred's upgraded to Buy from Neutral at Sidoti
02/07/17
02/07/17
UPGRADE

Buy
Follow-up: Fred's upgraded to Buy on valuation at Sidoti
As previously reported, Sidoti upgraded Fred's to Buy from Neutral. Analyst Gregory Pendy said the sharp pullback in shares provides a buying opportunity and maintained his $18 price target.

TODAY'S FREE FLY STORIES

FORR

Forrester

$41.60

0.15 (0.36%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
Forrester sees Q3 pro forma EPS 21c-25c, consensus 26c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

AHL

Aspen Insurance

$51.00

-0.75 (-1.45%)

16:27
07/26/17
07/26
16:27
07/26/17
16:27
Earnings
Aspen Insurance reports Q2 ops EPS 47c, consensus $1.00 »

Chris O'Kane, Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

OKE

Oneok

$55.59

-0.19 (-0.34%)

16:27
07/26/17
07/26
16:27
07/26/17
16:27
Hot Stocks
Oneok raises quarterly dividend 21% to 74.5c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

MB

Mindbody

$26.10

-0.05 (-0.19%)

16:27
07/26/17
07/26
16:27
07/26/17
16:27
Earnings
Breaking Earnings news story on Mindbody »

Mindbody sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

TYL

Tyler Technologies

$181.33

0.32 (0.18%)

16:27
07/26/17
07/26
16:27
07/26/17
16:27
Earnings
Tyler Technologies sees FY17 EPS $3.83-$3.91, consensus $3.88 »

Sees FY17 GAAP revenues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 14

    Aug

  • 05

    Sep

INVA

Innoviva

$13.19

0.08 (0.61%)

16:27
07/26/17
07/26
16:27
07/26/17
16:27
Earnings
Innoviva reports Q2 adjusted EPS 35c, consensus 27c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

KEX

Kirby

$65.20

-0.2 (-0.31%)

16:26
07/26/17
07/26
16:26
07/26/17
16:26
Earnings
Kirby narrows 2017 EPS outlook to $1.80-$2.10, consensus $2.07 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

  • 02

    Aug

FORR

Forrester

$41.60

0.15 (0.36%)

16:26
07/26/17
07/26
16:26
07/26/17
16:26
Earnings
Forrester reports Q2 pro forma EPS 42c, consensus 30c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CAPL

CrossAmerica

$28.05

-0.62 (-2.16%)

16:26
07/26/17
07/26
16:26
07/26/17
16:26
Hot Stocks
CrossAmerica increases quarterly distribution 0.8% »

CrossAmerica Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

KEX

Kirby

$65.20

-0.2 (-0.31%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Kirby sees Q3 EPS 40c-55c, consensus 56c »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

  • 02

    Aug

MB

Mindbody

$26.10

-0.05 (-0.19%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Breaking Earnings news story on Mindbody »

Mindbody sees Q3 revenue …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

OTEX

OpenText

$34.42

1.08 (3.24%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Hot Stocks
OpenText closes acquisition of Covisint for $103M »

OpenText announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

GGG

Graco

$105.91

-1.86 (-1.73%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Graco raising FY17 sales growth view to mid-to-high single digits »

Prior outlook was mid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 25

    Sep

MLNX

Mellanox

$44.75

-0.55 (-1.21%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Mellanox sees Q3 revenue $222M-$232M, consensus $233.61M »

Sees Q3 adjusted gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 02

    Aug

TYL

Tyler Technologies

$181.33

0.32 (0.18%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Tyler Technologies reports Q2 EPS 91c, consensus 94c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 14

    Aug

  • 05

    Sep

JAZZ

Jazz Pharmaceuticals

$161.52

0.27 (0.17%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Hot Stocks
Jazz enters into license agreement with XL-protein for PASylation Technology »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

KEX

Kirby

$65.20

-0.2 (-0.31%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Kirby reports Q2 EPS 48c, consensus 51c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

  • 02

    Aug

MLNX

Mellanox

$44.75

-0.55 (-1.21%)

16:24
07/26/17
07/26
16:24
07/26/17
16:24
Earnings
Mellanox reports Q2 EPS adjusted EPS 44c, consensus 44c »

Reports Q2 revenue $212M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 02

    Aug

FFNW

First Financial Northwest

$16.49

0.08 (0.49%)

16:24
07/26/17
07/26
16:24
07/26/17
16:24
Earnings
Breaking Earnings news story on First Financial Northwest »

First Financial Northwest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

GGG

Graco

$105.91

-1.86 (-1.73%)

16:24
07/26/17
07/26
16:24
07/26/17
16:24
Earnings
Graco reports Q2 EPS $1.38 with items, consensus $1.06 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 25

    Sep

LPSN

LivePerson

$11.40

-0.05 (-0.44%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Earnings
LivePerson narrows FY17 adjusted EPS view to 7c-11c from 7c-12c »

Consensus is for FY17 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

MB

Mindbody

$26.10

-0.05 (-0.19%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Earnings
Mindbody reports Q2 EPS (5c), consensus (5c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

EW

Edwards Lifesciences

$115.61

-0.26 (-0.22%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Technical Analysis
Technical View: Edwards Lifesciences spikes after results in extended session »

Shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 15

    Aug

  • 21

    Aug

BPFH

Boston Private Financial

$15.10

-0.25 (-1.63%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Earnings
Boston Private Financial reports Q2 EPS 27c, consensus 22c »

Average Total Deposits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

ACGL

Arch Capital

$99.03

-0.09 (-0.09%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Earnings
Arch Capital reports Q2 EPS $1.25, consensus $1.20 »

Gross premiums written by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.